2022-09-19T10:00:00Z – Strong scientific Support for Biohit’s GastroPanel in International Consensus Report
2022-09-07T10:00:00Z – Biohit GastroPanel enters into global market by co-operation with Randox
2022-09-06T11:00:00Z – Changes to Biohit Oyj’s management
2022-09-02T09:00:00Z – Change of CEO at Biohit Oyj
2022-08-22T10:30:00Z – Changes to Biohit Oyj’s management
2022-08-10T06:30:00Z – BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2022
2022-08-09T10:00:00Z – Dyspeptic symptoms need early attention- domestic innovations GastroPanel®, ColonView-FIT® and Acetium® will help
2022-08-03T06:30:00Z – Positive profit warning: Biohit Oyj raises its guidance for 2022 and publishes preliminary information about the result of the first half-year
2022-06-16T06:30:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2022-06-15T13:00:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2022-05-25T11:00:00Z – Notice of Biohit Oyj’s Annual General Meeting
2022-05-10T08:00:00Z – Publication of Biohit Oyj Renumeration Report 2021
2022-05-09T11:00:00Z – Recent study from Japan confirms the value of original GastroPanel® biomarkers diagnosis of autoimmune atrophic gastritis.
2022-03-30T06:30:00Z – Publication of Biohit Oyj Annual Report 2021
2022-03-10T08:00:00Z – Biohit Oyj Extraordinary general meeting and board of directors meeting decisions
2022-02-16T07:30:00Z – BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2021
2022-02-15T08:00:00Z – NEW RECOMMENDATION BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION: All patients with suspected gastritis should be examined by Pepsinogen I, Pepsinogen II and Gastrin-17 biomarkers.
2022-02-09T12:00:00Z – Notice of Biohit Oyj's extraordinary general meeting
2022-02-08T12:00:00Z – Biohit has settled the dispute concerning a breach of the patent license agreement and therefore specifies its financial guidance for 2021
2022-01-18T13:00:00Z – Biohit Oyj Managers' Trancactions - Elomaa
2022-01-18T13:00:00Z – Biohit Oyj - Managers' Transactions - Hahtela
2022-01-18T13:00:00Z – Biohit Oyj - Managers' Transactions - Mäki
2022-01-18T13:00:00Z – Biohit Oyj - Managers' Transactions - Patrakka
2022-01-18T13:00:00Z – Biohit Oyj - Managers' Transactions - Siltala
2022-01-18T13:00:00Z – Biohit Oyj - Managers' Transactions - Söderström
2022-01-13T12:30:00Z – Biohit Oyj’s Financial Reporting and Annual General Meeting in 2022
2021-12-14T08:00:00Z – Recent clinical validation study confirms the accuracy of the new-generation GastroPanel® test in diagnosis of atrophic gastritis and Helicobacter pylori infection.
2021-12-09T12:00:00Z – Biohit Oyj Board of Directors decided on new option scheme
2021-08-11T06:30:00Z – Biohit Group Half Year Financial Report 2021
2021-08-10T13:15:00Z – CE marked GastroPanel® quick test on the market
2021-07-29T06:00:00Z – Päivi Siltala new CEO of Biohit Oyj
2021-06-29T06:30:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2021-06-28T11:01:00Z – Changes in Management Team
2021-06-23T12:45:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2021-05-28T11:00:00Z – Notice of Biohit Oyj’s annual general meeting
2021-05-28T11:00:00Z – Publication of Biohit Oyj Renumeration Report 2020
2021-05-24T10:30:00Z – Changes to Biohit Oyj’s management
2021-05-21T11:30:00Z – Changes to Biohit Oyj’s management
2021-05-17T15:30:00Z – Biohit Oyj’s President and CEO Semi Korpela to leave the company
2021-05-17T15:30:00Z – Biohit corporation initiates arbitration proceedings concerning a breach of the license agreement
2021-04-26T07:59:18Z – Biohit Oyj comments on the claims presented in public by a member of Biohit board of directors, Mr. Liu Feng
2021-04-20T10:00:00Z – A study from Italy confirms: Low levels of G-17 biomarker of the Biohit GastroPanel® test predict the risk of esophagitis and esophageal reflux disease (GERD)
2021-04-08T10:00:00Z – Austell Pharmaceuticals starts as a new distributor of Biohit Oyj’s GastroPanel[®] test in South Africa
2021-03-26T13:35:00Z – Publication of Biohit Oyj Annual Report 2020
2021-03-26T07:01:02Z – Biohit’s CEO is on sick leave
2021-03-08T08:00:00Z – European Union and Business Finland provide Biohit Oyj with a total of EUR 900,000 in financing for product development
2021-03-03T15:00:00Z – Biohit Plc - Managers' transactions - Aiolfi
2021-03-03T15:00:00Z – Biohit Plc - Managers' transactions - Aiolfi
2021-02-23T08:02:16Z – Biohit Oyj Managers' Transactions
2021-02-17T07:30:00Z – Biohit group financial statement release 2020
2020-12-14T07:30:00Z – TPX Medik appointed as the exclusive distributor of GastroPanel® test in Malaysia
2020-12-09T12:30:00Z – Biohit Oyj’s Financial Reporting and Annual General Meeting in 2021
2020-09-25T12:00:00Z – Biohit GastroPanel[®] test was studied clinically in patients with autoimmune disease
2020-09-16T15:48:39Z – Correction: Decisions of the Annual General Meeting of Biohit Oyj
2020-09-16T15:00:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2020-09-16T12:30:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2020-08-21T14:30:00Z – Notice of Biohit oyj’s annual general meeting
2020-08-12T06:30:00Z – Biohit group half year financial report 2020
2020-08-06T07:05:00Z – The usefulness of Biohit GastroPanel[®] biomarkers in diagnosis of atrophic gastritis confirmed in a multi-center study in France
2020-06-04T15:00:00Z – Biohit Group’s Net Sales outlook for 2020 changed
2020-04-15T07:03:40Z – Does an undiagnosed atrophic gastritis (acid-free stomach) increase the risk of coronavirus infection, its complications and mortality particularly among elderly people?
2020-03-27T17:15:32Z – Correction: Biohit Oyj’s Annual Report 2019 is published
2020-03-27T16:24:28Z – Correction regarding the Stock exchange release: Biohit Oyj's 2020 Annual general meeting
2020-03-27T15:36:46Z – Publication of Biohit Oyj Annual Report 2019 and Renumeration Policy 2020
2020-03-27T15:00:00Z – Biohit oyj’s annual general meeting 2020
2020-03-12T08:00:00Z – Population-based screening by Biohit GastroPanel[®] biomarkers practically eliminates the risk of gastric cancer during a long-term follow-up
2020-02-19T07:30:00Z – Biohit Group Financial Statement Release 2019
2020-01-31T15:55:41Z – Biohit Plc - Managers' transactions - Aiolfi
2019-11-29T14:00:00Z – Biohit Oyj Financial Calendar, Biohit Oyj’s Financial Reporting and Annual General Meeting in 2020
2019-10-14T13:15:00Z – TREATMENT RECOMMENDATION IN RUSSIA: GastroPanel® biomarkers should be used for detection of gastrointestinal diseases
2019-08-14T06:30:00Z – BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
2019-08-09T12:30:00Z – Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
2019-06-12T10:15:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2019-06-03T09:15:00Z – Biohit Plc - Managers' transactions - Söderström
2019-05-20T07:30:00Z – May is the month for esophageal, intestinal and gastric health - How to prevent diseases and diagnose them early?
2019-04-25T06:30:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2019-04-24T16:30:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2019-04-17T06:30:00Z – Acetium® lozenge for smoking intervention will shortly be distributed in Italy within Difar Consumer Care® product division
2019-04-11T06:30:00Z – Acetium® lozenge for smoking intervention will be available in Thailand during the year 2019
2019-04-09T06:30:00Z – Biohit GastroPanel® biomarkers validated as powerful predictors of gastric cancer risk in a multicenter study
2019-04-04T06:30:00Z – Satya Abadi Pharma to distribute Acetium® lozenge in Indonesia
2019-03-29T07:30:00Z – Publication of Biohit Oyj Annual Report 2018
2019-03-29T07:30:00Z – Notice of Biohit Oyj’s Annual General Meeting
2019-03-25T07:30:00Z – Finns choose a domestic nicotine-free product as their preferred smoking intervention method
2019-02-27T11:30:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2019-02-20T07:30:00Z – BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018
2019-02-11T15:45:00Z – Biohit Oyj: Managers' Transactions
2019-02-04T12:26:23Z – International group of experts revisits the value of traditional Helicobacter tests (13C urea breath test and stool antigen test) in their critical review
2019-01-31T10:00:00Z – Business Development Director Lea Paloheimo will retire from Biohit Oyj
2019-01-28T12:30:27Z – Nicotine dependence is an increasing problem
2019-01-18T07:30:00Z – Biohit new-generation fecal immunochemical test (ColonView-FIT) is superior to traditional guaiac test in colorectal cancer screening
2018-12-31T12:00:00Z – Chief Medical Director Kari Syrjänen will retire from Biohit Oyj
2018-11-30T12:45:00Z – Biohit Oyj’s Financial Reporting and Annual General Meeting in 2019
2018-11-05T07:30:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2018-10-16T09:20:00Z – Stina Syrjänen resigns from Biohit Oyj’s Board of Directors
2018-10-05T09:10:00Z – Healthy Stomach Day – aroused wide interest and increased awareness on stomach health
2018-09-10T10:30:00Z – A new chance for a smoke-free life - Acetium® lozenges available across Finland
2018-09-07T12:00:00Z – The results of the migraine study will be delayed from the previously reported schedule
2018-09-05T07:10:00Z – Biohit GastroPanel® accurately predicted the progression of atrophic gastritis and its transition to gastric cancer in a European multicenter trial
2018-09-03T07:00:00Z – Retail Partner ApS to distribute Acetium® lozenge in Danmark and Sweden
2018-08-28T12:48:00Z – Biohit Oyj: Managers' Transactions
2018-08-27T13:50:00Z – Biohit Oyj: Managers' Transactions
2018-08-27T13:15:00Z – Biohit Oyj: Managers' Transactions
2018-08-27T10:00:00Z – Amendment: Biohit Oyj Managers' Transactions
2018-08-24T11:30:00Z – Biohit Oyj: Managers' Transactions
2018-08-24T11:30:00Z – Biohit Oyj: Managers' Transactions
2018-08-22T06:30:00Z – BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2018
2018-08-16T14:00:00Z – Decisions of the Extraordinary General Meeting of Biohit Oyj
2018-07-30T06:30:00Z – Changes to Biohit Oyj’s management
2018-07-05T06:30:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2018-07-02T06:30:00Z – NOTICE OF BIOHIT OYJ’S EXTRAORDINARY GENERAL MEETING
2018-06-19T06:30:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2018-06-08T12:45:00Z – Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
2018-06-08T12:40:00Z – Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
2018-06-08T12:30:00Z – Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
2018-06-08T12:25:00Z – Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
2018-06-08T12:15:00Z – Biohit Oyj: Managers' Transactions
2018-06-08T12:15:00Z – Biohit Oyj: Managers' Transactions
2018-06-08T12:00:00Z – Biohit Oyj: Managers' Transactions
2018-06-08T11:40:00Z – Biohit Oyj: Managers' Transactions
2018-05-31T06:30:00Z – Biohit Oyj’s Stock Exchange Release on 31 May 2018, 9:30 AM local (EEST)
2018-04-30T08:00:00Z – Changes to Biohit Oyj’s Management Team
2018-04-25T17:00:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2018-04-13T06:30:00Z – BIOHIT OYJ’S OWNERSHIP IS EXPANDING
2018-04-04T06:30:00Z – NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING
2018-04-03T06:30:00Z – Publication of Biohit Oyj Annual Report 2017
2018-03-12T11:00:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2018-03-12T08:30:00Z – Quit smoking, nicotine free: Oriola to distribute Acetium® lozenge in Finland
2018-03-05T12:10:00Z – Biohit Oyj - Managers' Transactions
2018-03-05T12:00:00Z – Biohit Oyj - Managers' Transactions
2018-02-28T07:30:00Z – Biohit Group Financial Statement Release 2017
2018-02-23T12:07:54Z – Update: Montebello to distribute Biohit products in Norway
2018-02-23T08:00:00Z – Montebello to distribute Biohit products in Norway
2018-02-22T11:00:00Z – Biohit GastroPanel® test helps reducing unnecessary gastroscopies in pre-operative evaluation of the patients referred for bariatric surgery
2018-02-20T07:30:00Z – Changes to Biohit Oyj’s Management Team
2018-02-15T07:30:00Z – Dow BioMedica to distribute Biohit GastroPanel® in Korea
2018-01-30T10:45:00Z – Quit smoking without nicotine: Pharmathen Hellas S.A. to distribute Acetium® lozenge in Greece
2018-01-05T12:30:00Z – Biohit Oyj’s comments on its Chinese distributor’s announcement
2017-12-18T07:30:00Z – Quit smoking, nicotine free: R-kioski to distribute Acetium® lozenge in Finland
2017-12-08T14:00:00Z – Biohit Oyj’s Financial Reporting and Annual General Meeting in 2018
2017-11-06T07:30:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2017-10-11T06:30:00Z – Biohit Oyj - Managers' Transactions
2017-09-11T07:30:00Z – An important patent granted to Biohit Acetium® Capsule in Japan
2017-09-04T06:30:00Z – A new meta-analysis from independent scientists in Italy confirms the accuracy of Biohit GastroPanel® in diagnosis of atrophic gastritis
2017-08-22T10:55:00Z – Biohit Oyj - Managers' Transactions
2017-08-22T10:50:00Z – Biohit Oyj - Managers' Transactions
2017-08-22T10:45:00Z – Biohit Oyj - Managers' Transactions
2017-08-22T10:35:00Z – Biohit Oyj - Managers' Transactions
2017-08-22T10:30:00Z – Biohit Oyj - Managers' Transactions
2017-08-17T06:30:00Z – BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2017
2017-08-16T11:45:00Z – Biohit GastroPanel® was shown to be an accurate predictor of gastric cancer risk during a 12-year follow-up of 12.000 people in China
2017-08-02T06:30:00Z – The results of Biohit’s second smoking intervention trial have been published
2017-06-05T06:30:00Z – Chinmax Medical Systems Inc. to distribute Acetium® Lozenge in China
2017-05-31T11:00:00Z – Ownership arrangement in Biohit Oyj’s Chinese Joint Venture completed
2017-05-29T06:45:00Z – Biohit Oyj B-shares subscribed with Stock Options I 2013 B
2017-05-26T07:30:00Z – Biohit Oyj - Managers' Transactions
2017-05-22T06:30:00Z – Biohit Acetium® lozenge is a highly effective means to stop smoking – results confirmed in a new large-scale trial
2017-05-04T07:00:00Z – Lea Paloheimo appointed Biohit Oyj’s R&D and production director
2017-04-27T06:30:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2017-04-26T16:30:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2017-04-20T06:30:00Z – Biohit Oyj B-shares subscribed with Stock Options I 2013 B
2017-04-10T09:30:00Z – Biohit Oyj - Managers' Transactions
2017-04-04T08:15:00Z – Biohit Oyj - Managers' Transactions
2017-04-03T06:30:00Z – NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING
2017-03-23T07:30:00Z – Publication of Biohit Oyj Annual Report 2016
2017-03-03T09:10:00Z – Biohit Oyj - Managers' Transactions
2017-03-03T09:05:00Z – Biohit Oyj - Managers' Transactions
2017-03-03T09:00:00Z – Biohit Oyj - Managers' Transactions
2017-03-01T14:35:00Z – Biohit Oyj - Managers' Transactions
2017-03-01T11:55:00Z – CORRECTION: Biohit Oyj - Managers' Transactions
2017-03-01T10:00:00Z – Biohit Oyj - Managers' Transactions
2017-03-01T09:50:00Z – Biohit Oyj - Managers' Transactions
2017-03-01T09:45:00Z – Biohit Oyj - Managers' Transactions
2017-02-24T12:55:00Z – Biohit Oyj - Managers' Transactions
2017-02-24T12:50:00Z – Biohit Oyj - Managers' Transactions
2017-02-24T12:45:00Z – Biohit Oyj - Managers' Transactions
2017-02-24T12:40:00Z – Biohit Oyj - Managers' Transactions
2017-02-24T12:35:00Z – Biohit Oyj - Managers' Transactions
2017-02-24T12:30:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T15:30:00Z – CORRECTION: Biohit Oyj - Managers' Transactions
2017-02-23T14:00:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:55:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:50:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:45:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:40:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:35:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:25:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:20:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:15:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:10:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:05:00Z – Biohit Oyj - Managers' Transactions
2017-02-23T13:00:00Z – Biohit Oyj - Managers' Transactions
2017-02-20T07:30:00Z – BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2016
2017-02-20T07:29:00Z – Biohit Oyj’s CEO Semi Korpela will return to work on 20.2.2017
2017-01-05T11:00:00Z – Biohit Oyj CEO Semi Korpela takes sick leave
2017-01-02T07:30:00Z – Ownership arrangement in Biohit Oyj’s Chinese Joint Venture – 2017 operating result expected to be positive
2016-12-19T07:30:00Z – GastroPanel® examination now possible from a whole blood sample
2016-12-05T16:00:00Z – Biohit Oyj - Managers' Transactions
2016-12-05T15:45:00Z – Biohit Oyj - Managers' Transactions
2016-12-05T15:30:00Z – Biohit Oyj - Managers' Transactions
2016-12-05T15:15:00Z – Biohit Oyj - Managers' Transactions
2016-12-05T13:00:00Z – Biohit Oyj’s Financial Reporting and Annual General Meeting in 2017
2016-12-05T12:30:00Z – Biohit Oyj’s Option Scheme I 2013 – Management Option Arrangement
2016-11-16T07:30:00Z – Biohit Oyj and R-kioski to start cooperation
2016-11-14T07:30:00Z – Biohit Oyj unveils groundbreaking GastroPanel® quick test
2016-11-08T07:30:00Z – Acetium capsule prevents the exposure to carcinogenic acetaldehyde in patients with atrophy of the stomach mucosa
2016-10-24T06:30:00Z – Biohit Oyj’s Chinese joint venture to start production - Gastric cancer risk screening study progressing in China
2016-09-21T06:30:00Z – The first meta-analysis of the scientific studies conducted with GastroPanel® has been completed – the test is accurate for diagnosing atrophic gastritis
2016-09-02T12:00:00Z – Glomedics to distribute Biohit Lactose Intolerance Quick Test in South Korea
2016-08-26T06:30:00Z – Ilari Patrakka appointed Biohit Oyj’s Sales and Marketing Director
2016-08-22T06:30:00Z – Beijing HuayiHuilang Medical Instrument Co., Ltd. to distribute GA-mapTM Dysbiosis Test in China
2016-08-18T06:30:00Z – BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2016
2016-08-03T06:30:00Z – Simultaneous testing of GastroPanel® biomarkers is possible – preliminary study results have been completed
2016-08-01T10:45:00Z – GastroPanel® detects risk factors of gastric cancer – a population-based screening study in Russia has been completed
2016-07-28T07:00:00Z – Vitamin B12 deficiency remains undetected and untreated far too often particularly among elderly citizens
2016-07-11T06:30:00Z – Beijing HuayiHuilang Medical Instrument Co., Ltd. to distribute Biohit Celiac Disease Quick Test in China
2016-07-06T06:30:00Z – Biohit Oyj and Pyynikin Craft Brewery to start cooperation
2016-07-05T06:30:00Z – Changes to Biohit Oyj’s Management Team
2016-06-17T06:30:00Z – Biohit Oyj Stock Options I 2013 will be registered in the Finnish book-entry system
2016-05-23T10:45:00Z – More scientific evidence on GastroPanel® test – the test predicts gastric cancer risk even at 15-year follow-up
2016-05-18T06:30:00Z – Pooyandegan Pezeshki Pardis to distribute Biohit GastroPanel®-test in Iran
2016-05-17T06:30:00Z – Atrophic gastritis and vitamin B12 deficiency remain often undetected in elderly people – early diagnosis is important to prevent complications
2016-04-26T06:30:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2016-04-25T14:15:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2016-04-14T06:30:00Z – Biohit Oyj starts inviting participants in the confirmatory smoking intervention trial
2016-04-13T06:30:00Z – The scientific report on Biohit’s first smoking intervention trial has been accepted for publication
2016-04-08T13:45:00Z – Helicobacter pylori infection increases the risk for gastric cancer – Long-term follow-up of the screened population has been completed
2016-03-31T06:30:00Z – NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING
2016-03-24T07:30:00Z – Publication of Biohit Oyj Annual Report 2015
2016-03-17T10:45:00Z – Biohit and Tianjin Jingsheng Biological Technology Development Co. Ltd. to start co-operation
2016-03-02T10:30:00Z – Biohit and OnSite Diagnostic Labs India Pvt Ltd. to start co-operation
2016-02-25T07:30:00Z – BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2015
2016-02-22T15:00:00Z – Biohit Oyj’s Option Scheme I 2013 – International Sales Management Option Arrangement
2016-02-15T07:30:00Z – Biohit Oyj starts a confirmatory smoking intervention trial
2016-02-12T07:30:00Z – Biohit Oyj’s new B-shares have been registered with the Trade Register as a part of the share exchange agreement with Genetic Analysis AS
2016-01-22T14:00:00Z – Genetic Analysis AS general meeting has approved the share exchange with Biohit Oyj
2016-01-05T13:30:00Z – Biohit Oyj buys a share of Norwegian Genetic Analysis AS company with a directed share issue
2015-12-17T13:30:00Z – Biohit Oyj will change its financial reporting – in the future, the company will publish financial reviews twice a year
2015-12-16T13:30:00Z – Biohit Oyj’s Management Team Option Arrangement
2015-12-04T07:30:00Z – Biohit's Financial Reporting and Annual General Meeting in 2016